Site News

FSB’s Deputy CEO applauds Nestlé’s value-added attention to peanut allergies

 
Picture of Fairfield Connect Admin
FSB’s Deputy CEO applauds Nestlé’s value-added attention to peanut allergies
by Fairfield Connect Admin - Wednesday, 30 September 2020, 1:10 PM
 

FSB’s Deputy CEO, Mr Mohammed Zaidi, has trumpeted Nestlé’s totemic attention to peanut allergy prevention and for adjoining vision-to-value as it acquires Aimmune Therapeutics, the maker of pioneering peanut allergy treatments, in a $2.6 billion deal. More details